Systemic immune-inflammation index is associated with cardiac complications following acute ischemic stroke: A

Xiaodi Hao1, Mingfang Zhu1, Zhengyu Sun1

  • 1Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou University, Zhengzhou, Henan 450003, China.

Insights

The early systemic immune-inflammation (SII) index is higher in patients experiencing stroke-induced heart syndrome. This index independently predicts cardiac complications following acute ischemic stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Immunology

Background:

  • Stroke-induced heart syndrome is a frequent and serious complication of ischemic stroke.
  • It is associated with poor patient prognosis, necessitating further research into its mechanisms.
  • Understanding these mechanisms is crucial for improving clinical decision-making.

Purpose of the Study:

  • To investigate the association between the early systemic immune-inflammation (SII) index and cardiac complications after acute ischemic stroke.
  • To determine if the SII index can predict the development of stroke-heart syndrome.

Main Methods:

  • Prospective collection and retrospective analysis of acute ischemic stroke patients from January 2020 to August 2022.
  • Inclusion criteria: presentation within 24 hours of symptom onset, absence of infection or cancer.
  • Calculation of the SII index [(neutrophils × platelets/lymphocytes)/1000] from admission laboratory data.

Main Results:

  • 121 patients were analyzed; 24 (19.8%) developed cardiac complications within 14 days.
  • Patients with stroke-heart syndrome exhibited significantly higher SII levels (p<.001).
  • The SII index was an independent predictor of stroke-heart syndrome (aOR 5.089, p=.002).

Conclusions:

  • New-onset cardiovascular complications after stroke are common.
  • The early systemic immune-inflammation (SII) index is strongly associated with these complications.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
30
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144